PHARMAC - Notification of ciprofloxacin widening access decision for use in ears

17 September 2017  |   Attachment: 2017-09 Notification of ciprofloxacin widening access decision.pdf (117.11 KB)

Please find attached a notification to inform you about our decision
to widen funded access to ciprofloxacin 0.3% eye drops in Section B
(Community) of the Pharmaceutical Schedule. This was the subject of an
amended consultation letter dated 14 August 2017.


If you have any questions about this decision, you can email us at or call our toll-free number (9 am to 5 pm,
Monday to Friday) on 0800 66 00 50.


Kind regards,

Sarah Whittall


Sarah Whittall | Team Assistant, Operations

PHARMAC | PO Box 10 254 | Level 9, 40 Mercer Street, Wellington